Literature DB >> 22362502

Severe autonomic failure in moderate to severe aortic stenosis: prevalence and association with hemodynamics and biomarkers.

Christine S Zuern1, Christian Eick, Konstantinos D Rizas, Cosmina Stoleriu, Petra Barthel, Christian Scherer, Karin A L Müller, Meinrad Gawaz, Axel Bauer.   

Abstract

BACKGROUND: Severe autonomic failure (SAF) refers to combined abnormalities in reflex and tonic autonomic function. SAF indicates increased risk of death in post-infarction and heart failure patients, but has not been studied in aortic stenosis (AS). Here, we investigated SAF in patients with AS and tested its correlation with hemodynamic and biochemical markers.
METHODS: We prospectively enrolled 174 patients with moderate to severe AS in sinus rhythm (age 76 ± 9 years; mean aortic valve area 0.9 ± 0.3 cm(2)). Heart rate turbulence (as marker of autonomic reflex activity) and deceleration capacity (as marker of autonomic tonic activity) were calculated from 24-h Holter recordings. According to the previously published technology, SAF was considered present if both factors were abnormal.
RESULTS: 44 (25.3%) of the 174 patients had signs of SAF. Patients with SAF had lower left ventricular ejection fraction (LVEF: 48.1 vs. 54.8%; p = 0.002), lower mean aortic gradients (28 vs. 34 mmHg, p = 0.019), higher systolic pulmonary artery pressures (46.8 vs. 40.9 mmHg, p = 0.028), higher levels of brain natriuretic peptide (905 vs. 407 ng/l; p = 0.003) and higher levels of high sensitive troponin I (0.65 vs. 0.24 μg/l; p = 0.013). Impaired LVEF (≤50%) was the only independent factor associated with SAF, but only explained autonomic abnormalities in less than half of the patients.
CONCLUSIONS: In patients with moderate to severe AS prevalence of SAF is high. SAF correlates with hemodynamic and biochemical markers indicating increased risk. Future studies should evaluate the prognostic value of SAF in patients with AS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362502     DOI: 10.1007/s00392-012-0427-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  40 in total

1.  Angiographic estimation of left ventricular volume.

Authors:  J H Gault
Journal:  Cathet Cardiovasc Diagn       Date:  1975

2.  Additive and logistic EuroSCORE performance in high risk patients.

Authors:  Ganesh Shanmugam; Mark West; Geoff Berg
Journal:  Interact Cardiovasc Thorac Surg       Date:  2005-04-18

3.  Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

Authors:  Alec Vahanian; Helmut Baumgartner; Jeroen Bax; Eric Butchart; Robert Dion; Gerasimos Filippatos; Frank Flachskampf; Roger Hall; Bernard Iung; Jaroslaw Kasprzak; Patrick Nataf; Pilar Tornos; Lucia Torracca; Arnold Wenink
Journal:  Eur Heart J       Date:  2007-01-26       Impact factor: 29.983

Review 4.  Neurocardiogenic syncope.

Authors:  V K Somers; F M Abboud
Journal:  Adv Intern Med       Date:  1996

5.  Power spectral analysis of heart rate variability in children with aortic stenosis.

Authors:  Osman Küçükosmanoğlu; Nazan Ozbarlas; Ahmet Birand; Gulmira Z Kudaiberdieva
Journal:  Turk J Pediatr       Date:  2002 Apr-Jun       Impact factor: 0.552

6.  Heart rate variability in left ventricular hypertrophy.

Authors:  M K Mandawat; D R Wallbridge; S D Pringle; A A Riyami; S Latif; P W Macfarlane; A R Lorimer; S M Cobbe
Journal:  Br Heart J       Date:  1995-02

7.  Heart rate variability and heart rate turbulence in mild-to-moderate aortic stenosis.

Authors:  Ugur Arslan; Murat Ozdemir; Sinan Altan Kocaman; Serhat Balcioglu; Mustafa Cemri; Atiye Cengel
Journal:  Europace       Date:  2008-09-04       Impact factor: 5.214

8.  Impaired vagal heart rate control in aortic valve stenosis.

Authors:  K E Airaksinen; M J Ikäheimo; M J Koistinen; J T Takkunen
Journal:  Eur Heart J       Date:  1988-10       Impact factor: 29.983

9.  Central vasopressin in experimental aortic stenosis in the rat.

Authors:  F Muders; E P Kromer; U Bahner; D Elsner; B Ackermann; H Schunkert; M Palkovits; G A Riegger
Journal:  Cardiovasc Res       Date:  1995-03       Impact factor: 10.787

10.  Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk).

Authors:  Axel Bauer; Petra Barthel; Raphael Schneider; Kurt Ulm; Alexander Müller; Anke Joeinig; Raphael Stich; Antti Kiviniemi; Katerina Hnatkova; Heikki Huikuri; Albert Schömig; Marek Malik; Georg Schmidt
Journal:  Eur Heart J       Date:  2008-12-23       Impact factor: 29.983

View more
  4 in total

1.  Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR.

Authors:  Marcel Weber; Eva Brüggemann; Robert Schueler; Diana Momcilovic; Jan-Malte Sinning; Alexander Ghanem; Nikos Werner; Eberhard Grube; Wolfgang Schiller; Fritz Mellert; Armin Welz; Georg Nickenig; Christoph Hammerstingl
Journal:  Clin Res Cardiol       Date:  2015-05-13       Impact factor: 5.460

2.  Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome.

Authors:  Benjamin N Schaeffer; Meike Rybczynski; Sara Sheikhzadeh; Ruken Ö Akbulak; Julia Moser; Mario Jularic; Doreen Schreiber; Anne Daubmann; Stephan Willems; Yskert von Kodolitsch; Boris A Hoffmann
Journal:  Clin Res Cardiol       Date:  2015-06-02       Impact factor: 5.460

3.  Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access.

Authors:  Andrea Muensterer; Domenico Mazzitelli; Hendrik Ruge; Anke Wagner; Ina Hettich; Nicolo Piazza; Ruediger Lange; Sabine Bleiziffer
Journal:  Clin Res Cardiol       Date:  2013-05-11       Impact factor: 5.460

4.  Cardiac Autonomic Response to Active Standing in Calcific Aortic Valve Stenosis.

Authors:  José M Torres-Arellano; Juan C Echeverría; Nydia Ávila-Vanzzini; Rashidi Springall; Andrea Toledo; Oscar Infante; Rafael Bojalil; Jorge E Cossío-Aranda; Erika Fajardo; Claudia Lerma
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.